We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
124 hedge funds and large institutions have $1.63B invested in AbCellera Biologics in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more call options, than puts
Call options by funds: $43.3M | Put options by funds: $18.6M
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
32% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 25
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
7% more funds holding
Funds holding: 116 → 124 (+8)
5.26% more ownership
Funds ownership: 35.41% → 40.68% (+5.3%)
18% less capital invested
Capital invested by funds: $1.98B → $1.63B (-$349M)
Holders
124
Holders Change
+8
Holders Change %
+6.9%
% of All Funds
1.91%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.14%
New
33
Increased
43
Reduced
30
Closed
25
Calls
$43.3M
Puts
$18.6M
Net Calls
+$24.7M
Net Calls Change
-$10.3M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$33.8M |
| 2 |
BlackRock
New York
|
+$21.1M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$20.4M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$15.5M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9.98M |
Top Sellers
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$19.5M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$10.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$6.78M |
| 4 |
E
Ergoteles
New York
|
-$6.64M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.47M |
